Research indicates that CALML3-AS1, regulated via m6A modifications by ALKBH5 and YTHDC2, facilitates NSCLC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), while its silencing suppresses these malignant behaviors. Here, CALML3 is linked to non-small cell lung carcinoma.